Nuformix Directors Boost Stake in Fundraising Effort
Company Announcements

Nuformix Directors Boost Stake in Fundraising Effort

Nuformix Plc (GB:NFX) has released an update.

Nuformix plc has announced that its directors have participated in a recent fundraising effort, purchasing substantial shares as part of a £300,000 placement. Notably, Non-Executive Chairman Julian Gilbert and Non-Executive Director Maddy Kennedy each acquired 22 million shares, while Executive Director Dan Gooding purchased 12 million shares. This move underscores the company’s focus on drug repurposing in fibrosis and oncology, potentially signaling confidence in its strategic direction.

For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskNuformix Approves New Shares, Eyes Growth in Market
TipRanks UK Auto-Generated NewsdeskNuformix Announces Major Fundraising and Share Issuance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App